Handelsbanken Fonder Ab Aurinia Pharmaceuticals Inc. Transaction History
Handelsbanken Fonder Ab
- $25.3 Billion
- Q3 2024
A detailed history of Handelsbanken Fonder Ab transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 60,700 shares of AUPH stock, worth $486,207. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,700
Previous 53,600
13.25%
Holding current value
$486,207
Previous $306,000
45.42%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AUPH
# of Institutions
208Shares Held
58.1MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.7 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.9 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.8 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.14B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...